Nallakkandi Rajeevan

Abstract Schizophrenia and related psychoses occur in all human populations, with the highest rates of diagnosis among Black individuals and those of mainly African ancestry1. Decades of research have established a highly heritable and polygenic basis for schizophrenia, which is mostly shared across populations2,3,4. However, a recruitment bias towards European cohorts5 has led to discoveries that are poorly generalizable to African populations.

SARS-CoV-2 infection is believed to increase risk for several medical conditions long after acute illness. Such post–COVID-19 conditions (PCCs) involve multiple organ systems (1) and include pulmonary, cardiovascular, cerebrovascular, thromboembolic, neurocognitive, mental health, metabolic, renal, and gastrointestinal disorders ().

Abstract Accurate breast cancer (BC) risk assessment allows personalized screening and prevention. Prospective validation of prediction models is required before clinical application. Here, we evaluate clinical- and genetic-based BC prediction models in a prospective cohort of women from the Million Veteran Program.